These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 17205486)

  • 21. Assessing the antifungal activity of a new oral lipid-based amphotericin B formulation following administration to rats infected with Aspergillus fumigatus.
    Risovic V; Rosland M; Sivak O; Wasan KM; Bartlett K
    Drug Dev Ind Pharm; 2007 Jul; 33(7):703-7. PubMed ID: 17654018
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treatment failure in invasive aspergillosis: susceptibility of deep tissue isolates following treatment with amphotericin B.
    Paterson PJ; Seaton S; Prentice HG; Kibbler CC
    J Antimicrob Chemother; 2003 Nov; 52(5):873-6. PubMed ID: 14519673
    [TBL] [Abstract][Full Text] [Related]  

  • 23. SCH56592 treatment of murine invasive aspergillosis.
    Graybill JR; Bocanegra R; Najvar LK; Luther MF; Loebenberg D
    J Antimicrob Chemother; 1998 Oct; 42(4):539-42. PubMed ID: 9818757
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparative efficacies, toxicities, and tissue concentrations of amphotericin B lipid formulations in a murine pulmonary aspergillosis model.
    Olson JA; Adler-Moore JP; Schwartz J; Jensen GM; Proffitt RT
    Antimicrob Agents Chemother; 2006 Jun; 50(6):2122-31. PubMed ID: 16723574
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of amphotericin B treatment on kinetics of cytokines and parameters of fungal load in neutropenic rats with invasive pulmonary aspergillosis.
    Becker MJ; de Marie S; Fens MH; Verbrugh HA; Bakker-Woudenberg IA
    J Antimicrob Chemother; 2003 Sep; 52(3):428-34. PubMed ID: 12917249
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In vivo evaluation of the antifungal activity of sertraline against Aspergillus fumigatus.
    Treviño-Rangel RJ; Villanueva-Lozano H; Méndez-Galomo KS; Solís-Villegas EM; Becerril-García MA; Montoya AM; Robledo-Leal ER; González GM
    J Antimicrob Chemother; 2019 Mar; 74(3):663-666. PubMed ID: 30403787
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antifungal prophylaxis is effective against murine invasive pulmonary aspergillosis.
    Rieg G; Spellberg B; Schwartz J; Fu Y; Edwards JE; Sheppard DC; Ibrahim AS
    Antimicrob Agents Chemother; 2006 Aug; 50(8):2895-6. PubMed ID: 16870798
    [No Abstract]   [Full Text] [Related]  

  • 28. Nebulized amphotericin B combined with intravenous amphotericin B in rats with severe invasive pulmonary aspergillosis.
    Ruijgrok EJ; Fens MH; Bakker-Woudenberg IA; van Etten EW; Vulto AG
    Antimicrob Agents Chemother; 2006 May; 50(5):1852-4. PubMed ID: 16641459
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparative study on the efficacy of AmBisome and Fungizone in a mouse model of pulmonary aspergillosis.
    Takemoto K; Yamamoto Y; Ueda Y; Sumita Y; Yoshida K; Niki Y
    J Antimicrob Chemother; 2006 Apr; 57(4):724-31. PubMed ID: 16446374
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Aspergillus fumigatus biofilms in the clinical setting.
    Müller FM; Seidler M; Beauvais A
    Med Mycol; 2011 Apr; 49 Suppl 1():S96-S100. PubMed ID: 21254964
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacodynamics of itraconazole against Aspergillus fumigatus in an in vitro model of the human alveolus: perspectives on the treatment of triazole-resistant infection and utility of airway administration.
    Al-Nakeeb Z; Sudan A; Jeans AR; Gregson L; Goodwin J; Warn PA; Felton TW; Howard SJ; Hope WW
    Antimicrob Agents Chemother; 2012 Aug; 56(8):4146-53. PubMed ID: 22615280
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Invasive pulmonary aspergillosis].
    Niki Y; Matsushima T
    Ryoikibetsu Shokogun Shirizu; 1999; (24 Pt 2):312-5. PubMed ID: 10201210
    [No Abstract]   [Full Text] [Related]  

  • 33. Prophylactic efficacy of single dose pulmonary administration of amphotericin B inhalation powder in a guinea pig model of invasive pulmonary aspergillosis.
    Kirkpatrick WR; Najvar LK; Vallor AC; Wiederhold NP; Bocanegra R; Pfeiffer J; Perkins K; Kugler AR; Sweeney TD; Patterson TF
    J Antimicrob Chemother; 2012 Apr; 67(4):970-6. PubMed ID: 22240402
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Triazole-polyene antagonism in experimental invasive pulmonary aspergillosis: in vitro and in vivo correlation.
    Meletiadis J; Petraitis V; Petraitiene R; Lin P; Stergiopoulou T; Kelaher AM; Sein T; Schaufele RL; Bacher J; Walsh TJ
    J Infect Dis; 2006 Oct; 194(7):1008-18. PubMed ID: 16960790
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Multidimensional volumetric imaging of pulmonary infiltrates for measuring therapeutic response to antifungal therapy in experimental invasive pulmonary aspergillosis.
    Petraitis V; Petraitiene R; Solomon J; Kelaher AM; Murray HA; Mya-San C; Bhandary AK; Sein T; Avila NA; Basevicius A; Bacher J; Walsh TJ
    Antimicrob Agents Chemother; 2006 Apr; 50(4):1510-7. PubMed ID: 16569871
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Pulmonary aspergilloma].
    Matsushima T; Yoshida K
    Ryoikibetsu Shokogun Shirizu; 1999; (24 Pt 2):308-11. PubMed ID: 10201209
    [No Abstract]   [Full Text] [Related]  

  • 37. Efficacy of posaconazole and amphotericin B in experimental invasive pulmonary aspergillosis in dexamethasone immunosuppressed rats.
    Ullmann AJ; Krammes E; Sommer S; Buschmann I; Jahn-Muehl B; Cacciapuoti A; Schmitt HJ
    J Antimicrob Chemother; 2007 Nov; 60(5):1080-4. PubMed ID: 17855727
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibition of conidiophore development in Aspergillus fumigatus by an Escherichia coli DH5α strain, a promising antifungal candidate against aspergillosis.
    Balhara M; Ruhil S; Kumar M; Dhankhar S; Chhillar AK
    J Mycol Med; 2014 Mar; 24(1):1-12. PubMed ID: 23978655
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Single-dose pharmacodynamics of amphotericin B against Aspergillus species in an in vitro pharmacokinetic/pharmacodynamic model.
    Al-Saigh R; Siopi M; Siafakas N; Velegraki A; Zerva L; Meletiadis J
    Antimicrob Agents Chemother; 2013 Aug; 57(8):3713-8. PubMed ID: 23716054
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Disseminated invasive aspergillosis in an apparently immunocompetent host.
    Raja NS; Singh NN
    J Microbiol Immunol Infect; 2006 Feb; 39(1):73-7. PubMed ID: 16440127
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.